Prof. MD Zafer Gulbas jest specjalistą onkologii medycznej i hematologii, dyrektorem onkologii medycznej w Anadolu Medical Center i założycielem Bone Marrow Transplantation Center w Anadolu. Jest wysoko wykwalifikowanym hematologiem-onkologiem, specjalizującym się w przeszczepach szpiku kostnego, z wykształceniem z Hacettepe University Medical School, Anadolu University Medical School, Atatürk Pulmonary Diseases and Thoracic Surgery Center, Hadassah Medical Center, Fred Hutchinson Cancer Research Center, MDAnderson Cancer Research Center i Toronto University Princess Margaret Hospital.
Lekarz ukończył Szkołę Medyczną Hacettepe w 1985 roku i został specjalistą chorób wewnętrznych na Uniwersytecie Ege w 1990 roku. Pogłębiając swoją wiedzę, lekarz specjalizował się w hematologii i ukończył doktorat w Japońskiej Szkole Medycznej Mie w 1995 roku. Do 1997 roku lekarz awansował na stanowisko adiunkta, a następnie profesora hematologii na Uniwersytecie Ege. W 2003 roku lekarz kontynuował pracę jako profesor hematologii na Uniwersytecie Technicznym Karadeniz. Z ponad 65 artykułami naukowymi, 112 referatami na spotkaniach i 34 prezentacjami konferencyjnymi, lekarz jest uznawany za wkład w hematologię i przeszczepy szpiku kostnego.<\/p>
Dr Betül Tavil jest profesorem hematologii i onkologii dziecięcej, światowej klasy ekspertem w dziedzinie przeszczepów szpiku kostnego dla dzieci.
Dlaczego pacjenci ufają dr Tavil:
Turkish hematology centers offer comprehensive treatments for hemolytic anemia, including bone marrow transplants, immunosuppressive therapy, and surgical splenectomy. Specialized units at JCI-accredited clinics like Anadolu Medical Center and Medipol Mega provide definitive curative options for inherited conditions like sickle cell and thalassemia through advanced stem cell transplantation.
Bookimed Expert Insight: Turkey stands out for scale, with units like Medipol Mega and Emsey Hospital operating 45-bed bone marrow transplant centers. This high capacity allows Professor Dr. Zafer Gulbas at Anadolu to maintain an 81% success rate for autologous transplants. Patients often choose these centers because they combine high-volume experience with direct affiliations to major US medical institutions.
Patient Consensus: Patients emphasize the need for a precise hematology workup first, as the specific cause determines whether they receive steroids or a transfusion. Many note that while transfusions bring immediate relief, consistent follow-up testing is essential because the underlying hemolysis may still be active.
Turkish hospitals utilize high-resolution hemoglobin electrophoresis and direct antiglobulin tests to identify hemolytic anemia types. JCI-accredited centers in Istanbul perform advanced flow cytometry and genetic panels to distinguish between inherited and acquired disorders. Diagnosis often involves board-certified hematologists from institutions like Anadolu Medical Center.
Bookimed Expert Insight: While many general hospitals provide basic blood counts, centers like Anadolu Medical Center and Medipol Mega offer specialized Bone Marrow Transplant units and flow cytometry. These facilities handle a massive volume of complex blood disorders annually. Choosing a clinic with an integrated flow cytometry lab ensures faster results for rare hemolytic subtypes.
Patient Consensus: Patients emphasize the importance of requesting a complete hemolysis panel early. They also note that recent blood transfusions can sometimes interfere with testing accuracy.
Bone marrow transplant (BMT) is used in Turkey as a curative treatment for severe hemolytic anemias. Specialists perform this procedure for inherited conditions like thalassemia major and sickle cell disease. JCI-accredited centers in Istanbul provide these complex hematopoietic stem cell transplants for children and adults.
Bookimed Expert Insight: While many view BMT as a general procedure, Turkish centers like Medipol Mega and Emsey Hospital offer specialized pediatric-focused units. This specialization is critical because inherited hemolytic anemias are often diagnosed in childhood. Choosing a center with a large bed capacity typically ensures shorter waiting times for life-saving donor matching.
Patient Consensus: Patients emphasize that a precise subtype diagnosis is necessary before considering a transplant. They mention that Turkish hematologists focus on BMT as a last-resort but potentially curative option for severe disease.